Table 5 Extent of intervention done and fate
From: Risk factors affecting outcome of rhino-orbital-cerebral mucormycosis in COVID-19 patients
| Â | Total no. = 33 |
|---|---|
Interval from symptom onset to treatment | |
 Median (IQR) | 7 (4–10) |
 Range | 1–63 |
Endoscopic treatment | 24 (72.7%) |
Combined (endoscopic and external) | 7 (21.2%) |
External | 2 (6.1%) |
Total no. of surgical procedures | |
 0 | 2 (7.1%) |
 1 | 18 (64.3%) |
 2 | 7 (25.0%) |
 3 | 1 (3.6%) |
Inf. turb. | 32 (97.0%) |
Middle turb. | 31 (93.9%) |
MMA | 32 (97.0%) |
Septectomy | 17 (51.5%) |
Palatal debrid. | 3 (9.1%) |
Ethmoidectomy | 31 (93.9%) |
Sphenoidotomy | 25 (75.8%) |
Death | 9 (27.3%) |
Onset of death or discharge (days) | |
 Median (IQR) | 30 (14–30) |
 Range | 5–90 |